Vertex Pharmaceuticals Incorporated

NasdaqGS:VRTX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 98.88 B

Share Price

USD 385.65

Avg Daily Volume

1,574,827

Change (1 day)

2.84%

Change (1 year)

-18.69%

Change (YTD)

-4.23%

Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD 3.85 B

Vertex Pharmaceuticals Incorporated Operating Cash Flow is USD 3.85 B for the Trailing 12 Months (TTM) ending June 30, 2025, a -507.46% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD -944.00 M, a -123.20% change year over year.
Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 4.07 B, a 1.24% change year over year.
Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 4.02 B, a 89.49% change year over year.
Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 2.12 B, a -19.52% change year over year.